公开(公告)号：AU2003277884A1

公开(公告)日：2004-04-19

申请号：AU2003277884

申请日：2003-09-22

Applicant: BASF AG

Inventor： HASSELWANDER OLIVER ,  HABICH ANDREAS ,  HANSEN MORTEN M ,  HANSEN CARSTEN L ,  YDE BRIGITTE ,  OFTRING ALFRED ,  SCHONHERR MICHAEL ,  GUTH FELICITAS

IPC: A23K1/16 ,  A23L1/30 ,  A61K9/16 ,  A61K9/50 ,  A61K31/14 ,  A61K31/16 ,  A61K31/375 ,  A61P1/16 ,  A61P9/00 ,  A61P25/28 ,  A61K9/00 ,  A61K47/00

Abstract: The invention relates to novel choline ascorbate-containing formulations; processes for their preparation and their use in human or animal foods, or human or animal food supplements or pharmaceuticals.

公开(公告)号：ZA200209941B

公开(公告)日：2004-03-09

申请号：ZA200209941

申请日：2002-12-09

Applicant: BASF AG

Inventor： HASSELWANDER OLIVER ,  HAEHNLEIN WOLFGANG ,  KRAEMER KLAUS ,  SCHWEIKERT LONI

IPC: A23L1/30 ,  A23C9/158 ,  A23K1/16 ,  A23L1/305 ,  A23L2/52 ,  A23L33/00 ,  A23L33/15 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/7076 ,  A61K31/714 ,  A61P9/00 ,  A61P25/00 ,  C07D475/04 ,  A23L

Abstract: Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.

公开(公告)号：AU2002358548A1

公开(公告)日：2003-06-10

申请号：AU2002358548

申请日：2002-11-27

Applicant: BASF AG

Inventor： BEWERT WOLFGANG ,  HANSEN MORTON MOHR ,  HASSELWANDER OLIVER ,  SINDEL ULRIKE ,  PTOCK ARNE ,  HINZ WILLY ,  PFEIFFER ANGELIKA-MARIA ,  HABICH ANDREAS ,  KAESLER BRUNO

IPC: A23K20/158 ,  A23K40/10 ,  A23K40/20 ,  A23K40/30 ,  A23L33/12 ,  A61K8/02 ,  A61K8/04 ,  A61K8/36 ,  A61K8/37 ,  A61K9/14 ,  A61K9/16 ,  A61K9/50 ,  A61K31/201 ,  A61Q19/00 ,  A23L1/30 ,  A23K1/16 ,  A23L1/29

Abstract: The present invention relates to pulverulent formulations comprising at least one conjugated trans/-cis-octadecapolyenoic acid and also production and use thereof for use in foods, food supplements, feedstuffs, feed additives, pharmaceutical and cosmetic preparations.

公开(公告)号：DE19956848A1

公开(公告)日：2001-05-31

申请号：DE19956848

申请日：1999-11-26

Applicant: BASF AG

Inventor： AUWETER HELMUT ,  BOHN HERIBERT ,  HASSELWANDER OLIVER ,  RIEGER JENS ,  SCHROEDER HARTWIG ,  WEGNER CHRISTOPH

IPC: A23K1/16 ,  A23L1/275 ,  A23L1/30 ,  A61K8/04 ,  A61K8/30 ,  A61K8/35 ,  A61K9/10 ,  A61K9/14 ,  A61K9/50 ,  A61K9/51 ,  A61K31/12 ,  A61P1/16 ,  A61P3/06 ,  A61P35/00 ,  A61K7/00 ,  A61K35/78

公开(公告)号：NZ540473A

公开(公告)日：2007-01-26

申请号：NZ54047303

申请日：2003-11-11

Applicant: BASF AG

Inventor： AUWETER HELMUT ,  BOHN HERIBERT ,  HASSELWANDER OLIVER ,  RUNGE FRANK

IPC: A23L1/30 ,  A23K1/165 ,  A61K31/575

Abstract: Disclosed is a pulverulent phytosterol formulation comprising at least one phytosterol having a mean particle size of from 0.05 to 1 micrometre, wherein at least one phytosterol is present in partially amorphous form. The formulation as disclosed is useful for producing food supplements and as an additive to foods, animal feeds, pharmaceutical and cosmetic preparations.

公开(公告)号：DE102004050353A1

公开(公告)日：2006-04-20

申请号：DE102004050353

申请日：2004-10-15

Applicant: BASF AG

Inventor： KRAEMER KLAUS ,  HAUNERT FRANK ,  MATUSCHEK MARKUS ,  HASSELWANDER OLIVER ,  KLATT MARTIN JOCHEN

IPC: A61K31/385 ,  A61K31/4436 ,  A61P3/10

公开(公告)号：AU2003304369A1

公开(公告)日：2005-02-14

申请号：AU2003304369

申请日：2003-11-11

Applicant: BASF AG

Inventor： AUWETER HELMUT ,  BOHN HERIBERT ,  HASSELWANDER OLIVER ,  RUNGE FRANK

IPC: A23K1/00 ,  A23K1/16 ,  A23L1/30 ,  A61K8/02 ,  A61K8/63 ,  A61K31/575 ,  A61Q1/00 ,  A61Q19/00 ,  A23K1/165

Abstract: Powdered formulation (A) contains at least one phytosterol (I) and has a mean particle size of 0.01-100 micro-m. An Independent claim is also included for preparation of (A).

公开(公告)号：DE10158046A1

公开(公告)日：2003-06-05

申请号：DE10158046

申请日：2001-11-27

Applicant: BASF AG

Inventor： BEWERT WOLFGANG ,  MOHR HANSEN MORTON ,  HASSELWANDER OLIVER ,  SINDEL ULRIKE ,  PTOCK ARNE ,  HINZ WILLY ,  PFEIFFER ANGELIKA-MARIA ,  HABICH ANDREAS ,  KAESLER BRUNO

IPC: A23K20/158 ,  A23K40/10 ,  A23K40/20 ,  A23K40/30 ,  A23L33/12 ,  A61K8/02 ,  A61K8/04 ,  A61K8/36 ,  A61K8/37 ,  A61K9/14 ,  A61K9/16 ,  A61K9/50 ,  A61K31/201 ,  A61Q19/00 ,  A23L1/29 ,  A23P1/02 ,  A23P1/12 ,  A23K1/16 ,  A61K31/202 ,  A61K7/00

Abstract: The invention relates to powder formulations, comprising at least one conjugated trans-/cis-octadecapolyenic acid and the production and use thereof for application in foodstuffs, foodstuff adjuncts, animal feeds, animal feed adjuncts, and pharmaceutical and cosmetic preparations.

公开(公告)号：CA2435077A1

公开(公告)日：2002-07-25

申请号：CA2435077

申请日：2002-01-16

Applicant: BASF AG

Inventor： OBERFRANK UWE ,  HASSELWANDER OLIVER ,  KRAMER KLAUS

IPC: A23K20/158 ,  A23L33/12 ,  A61K31/20 ,  A61K31/202 ,  A61P3/10 ,  A61P9/00 ,  A61P31/18 ,  A61P35/00 ,  A61P37/08 ,  A23L1/30 ,  A23K1/16

Abstract: The invention relates to food, dietary or pharmaceutical preparations, containing conjugated trans/cis octadecatrienic acids and methods for production thereof. Said preparations preferably contain calendulic acid. Th e invention further relates to the use of the preparations for the reduction o f dietary uptake in humans and animals and for improved dietary utilisation.

公开(公告)号：AU8405701A

公开(公告)日：2002-03-26

申请号：AU8405701

申请日：2001-09-11

Applicant: BASF AG

Inventor： HASSELWANDER OLIVER ,  KRAEMER KLAUS ,  BALDENIUS KAI-UWE ,  KLATT MARTIN JOCHEN ,  SCHWEIKERT LONI

IPC: A61K31/381 ,  A23L1/30 ,  A61K31/00 ,  A61K31/202 ,  A61K31/385 ,  A61P3/10 ,  A61P9/10 ,  A61P13/12 ,  A61P25/02 ,  A61P27/02

Abstract: The present invention relates to the use of lipoic acid, a physiologically acceptable derivative or salt thereof and one compound of the formula I H3C-(CH2)n1-(CH=CH)n3-(CH2)n2-COOH I in which n1, n2 have, independently of one another, the value of an integer from 3 to 9, n3 has the value of an integer from 2 to 6, and the number of carbon atoms is 18, 20 or 22, a physiologically acceptable derivative or salt thereof, for nutritional supplementation, in functional foods and for therapeutic purposes in the treatment of diabetic disorders. Compositions having a corresponding active ingredient combination, and compositions in the form of commercial packs with corresponding combination products or single-drug products for combined use are also described.